COVID-19 Real-Time PCR Test

CTKs COVID-19 Real-Time PCR Test has 97.5% sensitivity, >99.9% specificity by utilizing multiplex PCR-fluorescent probe technology combined with fast, one-step RT-PCR technology.
With the designed dual-target gene detection primer-probe, the test is designed to work with open PCR systems, making CTKs COVID-19 Real-Time PCR Test a practical solution for all varieties of laboratories.
Furthermore, CTK is working to submit its PCR test to the Foundation for Innovative New Diagnostics (FIND) in response to FINDs expression of interest (EOI) for evaluating assays using its standardized, independent protocol. CTK is also participating in the WHO program In-Vitro diagnostics for SARS-CoV-2 for emergency use listing.
1. Clinical Performance
Sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) forAridiaCOVID-19 Real-Time PCR Test compared with Charit protocol are >99.9%.
2. Analytical Specificity
The analytical specificity forAridiaCOVID-19 Real-Time PCR Test was confirmed by testing a panel consisting of different microorganisms representing the most common respiratory pathogens. No cross-reactivity was detected between any of the microorganisms tested.
For use with nasal swab specimens, sputum specimens, etc.
Detects ORF1ab, nucleocapsid protein gene.
Test packaging: 96 tests/kit.
LOD: 10 RNA copies per reaction.